Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Yokohama Municipal Citizen's Hospital, Yokohama-Shi, Japan

2 abstracts

Abstract
A multicenter, prospective phase II trial of first-line osimertinib treatment for patients with poor performance status and EGFR mutation–positive non-small cell lung cancer (OPEN/TORG2040).
Org: Kitasato Univeristy Hospital, Sagamihara-Shi, Japan, Toho University Omori Medical Center, Tokyo, Japan, Division of Respirology Neurology and Rheumatology Department of Internal Medicine, Kurume University Hospital, Kurume, Japan, Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan, Tochigi Cancer Center, Utsunomiya, Japan,
Abstract
Survival analysis by tumor response of nivolumab treatment in previously treated advanced gastric cancer from the DELIVER trial (JACCRO GC-08).
Org: St. Marianna University School of Medicine, Osaki Citizen Hospital, Sakai City Medical Center, Teine Keijinkai Hospital, Ikeda City Hospital,